| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/05/2023 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 689 | $39.10 | $26.9k | | 01/04/2023 |
| 01/05/2023 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 1.6k | $38.22 | $62.7k | | 01/04/2023 |
| 01/04/2023 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 2.5k | $37.21 | $93.3k | | 01/04/2023 |
| 01/01/2023 | Intellia Therapeutics, Inc. | NTLA | Exercise | Restricted Stock Unit | 3.5k | $0.00 | $0 | | 01/01/2023 |
| 06/17/2022 | Taysha Gene Therapies, Inc. | | Grant | Stock Option (right to buy) | 15.5k | $2.81 | $43.6k | | 06/17/2022 |
| 03/01/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 13.8k | $79.85 | $1.1M | | 01/01/2022 |
| 03/01/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 20.2k | $79.85 | $1.6M | | 03/01/2022 |
| 03/01/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | | 13.8k | $0.00 | $0 | | 01/01/2022 |
| 01/01/2022 | Intellia Therapeutics, Inc. | NTLA | Exercise | Restricted Stock Unit | 3.5k | $0.00 | $0 | | 01/01/2022 |
| 01/01/2022 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 1.1k | $112.25 | $128.9k | | 01/01/2022 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 2.7k | $159.64 | $423.5k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 1.5k | $158.90 | $240.7k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 3.9k | $157.77 | $620.4k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 207 | $160.47 | $33.2k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 27k | $13.40 | $361.8k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 70k | $14.25 | $997.5k | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 7.4k | $156.79 | $1.2M | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 16.1k | $155.61 | $2.5M | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 28.7k | $154.77 | $4.4M | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 20.6k | $153.64 | $3.2M | | 08/30/2021 |
| 08/30/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 15.8k | $152.75 | $2.4M | | 08/30/2021 |
| 08/04/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 126 | $141.63 | $17.8k | | 08/04/2021 |
| 08/04/2021 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 26k | $13.40 | $348.4k | | 08/04/2021 |
| 08/04/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 1.5k | $135.47 | $199.3k | | 08/04/2021 |
| 08/04/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 6.8k | $136.79 | $932.1k | | 08/04/2021 |
| 08/04/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 6.3k | $137.72 | $873.7k | | 08/04/2021 |
| 08/04/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 4.4k | $138.78 | $613.3k | | 08/04/2021 |
| 08/04/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 2.8k | $139.85 | $387.7k | | 08/04/2021 |
| 08/04/2021 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 4.1k | $140.73 | $570.5k | | 08/04/2021 |
| 06/17/2021 | Taysha Gene Therapies, Inc. | | Grant | Stock Option (right to buy) | 15.5k | $25.04 | $388.1k | | 06/17/2021 |
| 03/03/2021 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 84k | $57.71 | $4.8M | | 03/03/2021 |
| 03/03/2021 | Intellia Therapeutics, Inc. | NTLA | Grant | Restricted Stock Unit | 14k | $0.00 | $0 | | 03/03/2021 |
| 11/23/2020 | Taysha Gene Therapies, Inc. | | Grant | Stock Option (right to buy) | 31k | $21.77 | $674.9k | | 11/23/2020 |
| 03/02/2020 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (Right to Buy) | 135k | $13.40 | $1.8M | | 03/02/2020 |
| 06/03/2019 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (Right to Buy) | 150k | $14.25 | $2.1M | | 06/03/2019 |